Deals channel feed – Endpoints News

Deals channel feed

Dr. Reddy's and Stanford spinout Kainomyx partner up on anti-malarial program

9 months ago

J&J buys another medtech company, this time paying $600M upfront for Israel-based V-Wave

9 months ago

Merck rejigs ADC deal with Kelun, grabbing one program and returning another

9 months ago

Walgreens nabs $100M BARDA partnership to expand decentralized clinical trials

9 months ago

Avantor sells off CRO for $650M to private equity firm

9 months ago

Sanofi backs AnaptysBio’s $100M offering, helping catapult the biotech’s stock

9 months ago

Revance to be acquired for $900M+ as Botox trade secrets lawsuit continues

9 months ago

Merck pays $700M for clinical-stage CD3xCD19 bispecific antibody

9 months ago

Gilead shells out $320M to J&J to buy out rare liver disease drug royalties

9 months ago

Updated: Recursion to acquire Exscientia to bolster pipeline in one of AI bio’s biggest M&A deals

9 months ago

Pfizer got a $1.2B payout for its stake in Cerevel

9 months ago

Private Danish iron deficiency biotech to buy G1 Therapeutics for $405M

9 months ago

Eisai picks SEED Therapeutics for molecular glue deal worth as much as $1.5B

9 months ago

Genentech partners with cash-strapped Sangamo on epigenetic Alzheimer’s therapy

9 months ago

Merck enlists partner Daiichi Sankyo to develop T cell engager from Harpoon acquisition

9 months ago

Mallinckrodt sells photopheresis platform Therakos for $925M

9 months ago

Third Rock and Arie Belldegrun’s firm come together for CD20/CD3 bispecific out of China

9 months ago

What the meltdown in the stock market means for biotech and pharma

9 months ago

BioNTech says no to Phase 3 with Genmab’s bispecific antibody

9 months ago

Bristol Myers returns TIGIT bispecific to Agenus, frees itself from $1B+ milestones

9 months ago

23andMe board rejects Anne Wojcicki’s take-private plan, requests changes

9 months ago

Galapagos pauses blood cancer CAR-T therapy trial due to one Parkinsonism event

9 months ago

Vir's overhaul brings an end to most virology work — and a beginning with cancer

10 months ago

AbbVie closes $8.7B Cerevel deal in bid to compete with Bristol Myers in schizophrenia

10 months ago

First page Previous page 11 12 131415 16 17 Next page Last page